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We thank Chahine and colleagues
for their letter in response to our arti-
cle discussing on-pump and off-
pump coronary artery bypass grafting
in patients with left main stem dis-
ease.1 We never claimed that off-
pump coronary artery bypass surgery
is the best strategy for patients with
left main disease. Our conclusion
was that ‘‘off-pump coronary artery
surgery in patients with left main
stem disease is a safe procedure that
will reduce morbidity and mortality
and similar long-term survival com-
pared with conventional on-pump
revascularization.’’
We are aware of the results of the 2
recent randomized studies referred to
in the letter. The Coronary Artery By-
pass Grafting Off or On Pump Revas-
cularization trial2 did not demonstrate
any substantial difference between the
2 techniques, and the study concluded
that ‘‘There was no significant differ-
ence between off-pump and on-pump
CABG with respect to the 30-day
rate of death, myocardial infarction,
stroke, or renal failure requiring dialy-
sis.’’ Those authors go on to say, ‘‘The
use of off-pump CABG resulted in
reduced rates of transfusion, reopera-
tion for perioperative bleeding, res-
piratory complications, and acute
kidney injury but also resulted in an
increased risk of early revasculariza-
tion.’’2 However, investigators in the
Veterans Affairs Randomized On/Off
Bypass trial3 concluded that the
results of surgeries performed off-
pump were inferior to conventional
on-pump coronary artery bypass graft
surgery. That study, as pointed out in1274 The Journal of Thoracic anda recent editorial,4 had several major
limitations. More than 70% of eligi-
ble patients (ie, scheduled for urgent
or elective coronary artery bypass
grafting) were excluded because of
clinical reservations of the surgical
team or small target vessels. This sug-
gests inexperience on the part of sur-
geons in the trial, who were required
to have performed just 20 off-pump
coronary artery bypass procedures
(OPCAB) to participate. Conversion
to on-pump coronary artery bypass,
which is known to increase morbidity
and mortality, occurred in>12% of
cases, much greater than the 1% to
3% reported by centers specializing
in OPCAB. In the OPCAB group,
>50% of patients received red blood
cell transfusions, which contrasts
with the 30% in previous randomized
trials. Finally, only a small minority of
the studied population were high-risk
patients, a group more likely to benefit
from OPCAB.
At the Bristol Heart Institute we
have been performing OPCAB sur-
gery for>17 years. We are a high vol-
ume center, with OPCAB accounting
for 70% of all coronary procedures.
We recognize that OPCAB surgery is
a technically demanding procedure
that should be performed in a high
volume center to obtain optimal out-
come. We think that OPCAB is a tech-
nique for the many and not the few
(both surgeons and patients) but only
with structured training and supervi-
sion in the right environment.4
Finally, with regard to the specific
question on the incidence of stroke, in
our article we reported a similar 0.4%
incidence of transient cerebrovascular
accident (CVA) in both groups and
0% and 0.9% of permanent CVA in
the off-pump and on-pump groups, re-
spectively. With off-pump procedures
it is possible to minimize manipulation
of the aorta because there is no require-
ment for cannulation when performing
total arterial revascularization. How-
ever, in our series a majority of patients
also receivedvein grafts thatwere anas-
tomosed to the ascending aorta usingCardiovascular Surgery c November 20a side bite exclusion clamp. The inci-
dence of CVA was low regardless if
patients were operated on using the
on-pump or off-pump technique. We
have no reason to believe that this infor-
mation is inaccurate given that it was
obtained fromour institution’s prospec-
tively collected database. Permanent
CVA is a clearly defined event that is
most unlikely to have been missed by
our clinicians.
Gianni D. Angelini, MD
Michele Murzi, MD
Bristol Heart Institute
University of Bristol
Bristol, United Kingdom
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To the Editor:
With great interestwe have read a re-
cent article from Deja and colleagues1
on preoperative aspirin in an elective
coronary artery bypass grafting popu-
lation. The authors conducted a sin-
gle-center, double-blind, randomized
trial comparing its effects to placebo.
The primary endpoints were more
than 750 mL of bleeding during the
first 12 hours postoperatively and12
